The Affiliated Hospital Of Xuzhou Medical University

This early-phase study is testing a new type of 'off-the-shelf' CAR T-cell therapy for people with severe, hard-to-treat autoimmune diseases like lupus and inflammatory myopathy. The therapy uses immune cells from a healthy donor, modified to target and remove certain harmful B c…

This study is testing if a monthly injectable drug called tafolecimab can help people who have just had a heart attack. Researchers want to see if the drug lowers the risk of having another major heart problem within a year and improves blood flow in the small heart vessels. They…